EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions

Kelly E Lloyd iD, Louise H Hall iD, Lucy Ziegler iD, Robbie Foy iD, Gillian M Borthwick iD, Mairead MacKenzie, David G Taylor iD, Samuel G Smith iD, Aspirin for Cancer Prevention group

British Journal of General Practice · 2023-04 · 73 (729) · e302-e309

DOI: 10.3399/bjgp.2021.0610 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of General Practice, online erschienen am 14.12.2022. Verfasst von Kelly E Lloyd und 8 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Health Sciences, University of Leeds, Leeds. Hauptthemen laut MEDLINE: Aspirin, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The National Institute for Health and Care Excellence (NICE) 2020 guidelines recommends aspirin for colorectal cancer prevention for people with Lynch syndrome. Strategies to change practice should be informed by understanding the factors influencing prescribing.

Aim

To investigate the optimal type and level of information to communicate with GPs to increase willingness to prescribe aspirin. Design and setting GPs in England and Wales ( n = 672) were recruited to participate in an online survey with a 2 3 factorial design. GPs were randomised to one of eight vignettes describing a hypothetical patient with Lynch syndrome recommended to take aspirin by a clinical geneticist.

Method

Across the vignettes, the presence or absence of three types of information was manipulated: 1) existence of NICE guidance; 2) results from the CAPP2 trial; 3) information comparing risks/benefits of aspirin. The main effects and all interactions on the primary (willingness to prescribe) and secondary outcomes (comfort discussing aspirin) were estimated.

Results

There were no statistically significant main effects or interactions of the three information components on willingness to prescribe aspirin or comfort discussing harms and benefits. In total, 80.4% (540/672) of GPs were willing to prescribe, with 19.7% (132/672) unwilling. GPs with prior awareness of aspirin for preventive therapy were more comfortable discussing the medication than those unaware ( P = 0.031).

Conclusion

It is unlikely that providing information on clinical guidance, trial results, and information comparing benefits and harms will increase aspirin prescribing for Lynch syndrome in primary care. Alternative multilevel strategies to support informed prescribing may be warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinColorectal Neoplasms, Hereditary NonpolyposisHumansEnglandSurveys and QuestionnairesRisk Assessment

Stichwörter der Autor:innen

NSAID, preventive therapyaspirinchemopreventiondecision makingprimary health care

Substanzen

Aspirin

Autor:innen und Institutionen

  • Leeds Institute of Health Sciences, University of Leeds, Leeds.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle.
  • Independent Cancer Patients' Voice.
  • School of Pharmacy, UCL, London.

ORCID-Profile: Kelly E Lloyd, Louise H Hall, Lucy Ziegler, Robbie Foy, Gillian M Borthwick, David G Taylor, Samuel G Smith

Förderung

  • Cancer Research UK

Zitieren

APA

Lloyd, K. E., Hall, L. H., Ziegler, L., Foy, R., Borthwick, G. M., MacKenzie, M., Taylor, D. G., Smith, S. G., & Aspirin for Cancer Prevention group (2023). GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions. British Journal of General Practice, 73(729), e302-e309. https://doi.org/10.3399/bjgp.2021.0610

Vancouver

Lloyd KE, Hall LH, Ziegler L, Foy R, Borthwick GM, MacKenzie M, et al. GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions. British Journal of General Practice. 2023;73(729):e302-e309. doi:10.3399/bjgp.2021.0610

BibTeX
@article{Lloyd2023,
  author = {Lloyd, Kelly E and Hall, Louise H and Ziegler, Lucy and Foy, Robbie and Borthwick, Gillian M and MacKenzie, Mairead and Taylor, David G and Smith, Samuel G and Aspirin for Cancer Prevention group, Aspirin for Cancer Prevention group},
  title = {GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions},
  journal = {British Journal of General Practice},
  year = {2023},
  volume = {73},
  number = {729},
  pages = {e302--e309},
  doi = {10.3399/bjgp.2021.0610}
}
Kostenlos starten →